A human pituitary adenoma cell line proliferates and maintains some differentiated functions following expression of SV40 large T-antigen

Endocrine Pathology

Volumn 9, Issue 2, 1998, Pages 169-184

  Jin, Long ^a   Kulig, Elzbieta ^a   Qian, Xiang ^a   Scheithauer, Bernd W ^a   Eberhardt, Norman L ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cell culture; PCR; Pituitary; TGF

Indexed keywords

CHROMOGRANIN A; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; VIRUS LARGE T ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN VIRUS 40; TUMOR CELL LINE;

EID: 0031848885     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02782609     Document Type: Article

References (53)

1. Kohler PO, Bridson WE, Rayford PL, Kohler SE. Hormone production by human pituitary adenomas in culture. Metab Clin Exp 18:782-788, 1969.
2. O'Sullivan JP, Alexander KM, Jenkins JS. Maintenance of functioning human pituitary tumors in nude athymic mice. J Endocrinol 79:139-140, 1978.
3. Synder J, Hymer WC, Wilfinger WW. Culture of human pituitary prolactin and growth hormone cells. Cell Tissue Res 191:379-388, 1978.
4. Adams EF, Brajkovich IE, Mashiter K. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine. J Clin Endocrinol Metab 49:120-126, 1979.
5. Lipson LG, Beitins IZ, Komblith PL, McArthur JW, Friesen HG, Kliman B, et al. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium. Acta Endocrinol 90:421-433, 1979.
6. Wyche JH, Noteboom WD. Production of a growth factor in cultured human pituitary cells [Abstract]. J Cell Biol 75:81, 1977.
7. Wyche JH, Noteboom WD. Growth regulation of cultured human pituitary cells by steroidal and nonsteroidal compounds in defined medium. Endocrinology 104:1765-1773, 1979.
8. See YP, Sun AM, McComb DJ, Gerrie B, Kovacs K. Ultrastructural differentiation in the nude mouse of transformed cells isolated from the human fetal pituitary gland. Cancer Res 42:2336-2343, 1982.
9. Kikuchi Y, Seki K, Momose E, Kizawa I, Oomori K, Shima K, et al. Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma. Cancer Res 45:5722-5727, 1985.
10. Woodworth CD, Kreider JW, Mengel L, Miller T, Meng YL, Isom HC. Tumorigenicity of simian virus 40-hepatocyte cell lines. Effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes. Mol Cell Biol 8:4492-4501, 1988.
11. Van Doren K, Gluzman Y. Efficient transformation of human fibroblast by adenovirus-simian virus 40 recombinants. Mol Cell Biol 4:1653-1656, 1984.
12. Sen A, Dunnmon P, Henderson SA, Gerard RD, Chien KR. Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem 263:19,132-19,136, 1988.
13. Nakamigawa T, Momoi MY, Momoi T, Yanagisawa M. Generation of human myogenic cell lines by the transformation of primary culture with origin-defective SV40 DNA. J Neurol Sci 83:305-319, 1988.
14. Wyllie FS, Bond JA, Dawson T, White D, Davies R, Wynford-Thomas D. A phenotypically and karyotypically stable human thyroid epithelial line conditionally immortalized by SV40 large T antigen. Cancer Res 52:2938-2945, 1992.
15. Chou JY. Differentiated mammalian cell lines immortalized by temperature-sensitive tumor virus. Mol Endocrinol 3:1511-1514, 1989.
16. Lei K-J, Gluzman Y, Pan C-J, Chou JY. Immortalization of virus-free human placental cells that express tissue-specific functions. Mol Endocrinol 6:703-712, 1992.
17. Bernard R, Le Bert M, Borde I, Galiana E, Evrard C, Rouget P. Immortalization of different precursors of glial cells with a targeted and temperature-sensitive oncogene. Exp Cell Res 214:373-380, 1994.
18. Chou JY. Establishment of rat fetal liver lines and characterization of their metabolic and hormonal properties. Use of temperature-sensitive SV40 virus. Methods Enzymol 109: 385-396, 1985.
19. Hurst BS, Zilberstein M, Chou J-Y, Litman B, Stephens J, Leslie KK. Estrogen receptors are present in human granulosa cells. J Clin Endocrinol Metab 80:229-232, 1995.
20. Windle JJ, Weiner RI, Mellon PL. Cell lines of the pituitary gonadotype lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603, 1990.
21. Alarid ET, Windle JJ, Whyte DB, Mellon PL. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122: 3319-3329, 1996.
22. Jin L, Scheithauer BW, Young WF Jr, Davis DH, Klee GG, Lloyd RV. Pancreastatin secretion by pituitary adenoma and regulation of chromogranin B mRNA expression. Am J Pathol 148:2057-2066, 1996.
23. kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151:509-519, 1997.
24. Miller GM, Alexander JM, Klibanski A. Gonadotropin-releasing hormone messenger RNA expression in gonadotropin tumors and normal human pituitary. J Clin Endocrinol Metab 81:80-83, 1996.
25. Sanno N, Jin L, Qian X, Osamura RY, Scheithauer BW, Kovacs K, et al. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries. J Clin Endocrinol Metab 82:1974-1982, 1997.
26. Alexander JM, Klibanski A, Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro. J Clin Invest 93:2332-2339, 1994.
27. Lloyd RV, Cano M, Landefeld TD. The effects of estrogens on tumor growth and on prolactin and growth hormone mRNA expression in rat pituitary tissues. Am J Pathol 133:397-406, 1988.
28. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428, 1991.
29. Qian X, Jin L, Grande GP, Lloyd RV. Transforming growth factor-β and p27 expression in pituitary cells. Endocrinology 137:3051-3060, 1996.
30. 3H] thymidine uptake in HTC-4 and LLC-L1 tumor cells. J Surg Res 61:367-372, 1996.
31. Tashjian AH Jr, Yasumura Y, Levine L, Sato GH, Parker ML. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82:342-352, 1968.
32. Bloomquist BT, Eipper BA, Mains RE. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 5:2014-2024, 1991.
33. Thiny MT, Antczak C, Fields K, Jin L, Lloyd RV. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression. Lab Invest 70:899-906, 1994.
34. Mellon PL, Windle JJ, Weiner RI. Immortalization of neuroendocrine cells by targeted oncogenesis. Rec Prog Horm Res 47: 69-96, 1991.
35. Ozer HL, Slater ML, Dermody JJ, Mandel M. Replication of simian virus 40 DNA in normal human fibroblasts and in fibroblasts from xeroderma pigmentosum. J Virol 39: 481-489, 1981.
36. 3-1 cells: evidence for cross-talk between PKA and protein kinase C pathways. Endocrinology 138:2259-2266, 1997.
37. Oren M, Maltzman W, Levine AJ. Post-translational regulation of the 54K cellular tumor antigen in normal and transformal cells. Mol Cell Biol 1:101-110, 1981.
38. Mietz JA, Unger T, Huibregtse JM, Howley PM. The transcriptional transactivation function of wild type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBOJ 11:5013-5020, 1992.
39. Lloyd RV, Wilson BS. Specific endocrine tissue marker defined by a monoclonal antibody. Science 222:628-630, 1983.
40. Winkler H, Fischer-Colbrie R. The chromogranin A and B: the first 25 years and future perspectives. Neuroscience 49:497-528, 1992.
41. Huttner WB, Gerdes HH, Rosa P. The granin (chromogranin/secretogranin) family. Trend Biochem Sci 16:27-30, 1991.
42. Steiner DF, Smeekens SP, Ohagi S, Chan SJ. The new enzymology of precursor processing endoproteases. J Biol Chem 267:23,435-23,438, 1992.
43. Seidah NG, Chretien M. Pro-protein convertases of subtilisin/kexin family. Methods Enzymol 244:175-188, 1994.
44. Udupi V, Townsend CM Jr, Gomez G, Zhang T, Greeley GH Jr. Down regulation of prohormone convertase-1 by a phorbol ester. Biochem Biophys Res Commun 217:495-500, 1995.
45. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGF-beta type III receptor. Cell 67:797-805, 1991.
46. Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, et al. Expression of transforming growth factor-beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269:26,449-26,455, 1994.
47. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
48. Massague J, Polyak K. Mammalian anti-proliferative signals and their targets. Gurr Opinion Genet Dev 5:91-96, 1995.
49. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extra-cellular antimitogenic signals. Cell 78:59-66, 1994.
50. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994.
51. kip1 expression in endocrine and other tumors. Am J Pathol 150:1-7, 1997.
52. Castro MG, Goya RG, Sosa YE, Rowe J, Larregina A, Morelli A, et al. Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenovirus: long term expression, cell cycle dependency, and effects on hormone secretion. Endocrinology 138:2184-2194, 1997.
53. Ham J, Webster J, Bond JA, Jasani B, Lewis MD, Hepburn PJ, Davies JS, Lewis BM, Wynford T, THomas D, Scanlon MF. Immortalized human pituitary cells express glycoprotein α-subunit and thyrotropin B (TSHB). J Clin Endocrinol Metab 83: 1598-1603, 1998.